Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases.
Johansen ND, Vaduganathan M, Bhatt AS, Modin D, Claggett BL, Janstrup KH, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Køber L, Solomon SD, Sivapalan P, Jensen JUS, Martel CJ, Krause TG, Biering-Sørensen T. Johansen ND, et al. Among authors: janstrup kh. NEJM Evid. 2025 Nov 10:EVIDoa2500265. doi: 10.1056/EVIDoa2500265. Online ahead of print. NEJM Evid. 2025. PMID: 41213006
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
Johansen ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sánchez C, Loiacono MM, Harris RC, Dufournet M, van Aalst R, Chit A, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Duran-Parrondo C, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, Mirás-Carballal S, González-Pérez JM, Solomon SD, Sivapalan P, Martel CJ, Jensen JUS, Martinón-Torres F, Biering-Sørensen T; DANFLU-2 Study Group and the GALFLU Trial Team. Johansen ND, et al. Among authors: janstrup kh. Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.077801. Online ahead of print. Circulation. 2025. PMID: 41212981
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial.
Duus LS, Johansen ND, Modin D, Janstrup KH, Nealon J, Samson S, Loiacono MM, Harris RC, Larsen CS, Reimer Jensen AM, Claggett BL, Solomon SD, Landray MJ, Gislason GH, Køber L, Sivapalan P, Stæhr Jensen JU, Biering-Sørensen T. Duus LS, et al. Among authors: janstrup kh. Respir Investig. 2025 Nov 1;63(6):1309-1315. doi: 10.1016/j.resinv.2025.10.016. Online ahead of print. Respir Investig. 2025. PMID: 41177098 Free article.
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis.
Johansen ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sánchez C, Loiacono MM, Harris RC, Dufournet M, van Aalst R, Chit A, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Duran-Parrondo C, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, Mirás-Carballal S, González-Pérez JM, Solomon SD, Sivapalan P, Martel CJ, Jensen JUS, Martinón-Torres F, Biering-Sørensen T; DANFLU-2 Study Group; GALFLU Trial Team. Johansen ND, et al. Among authors: janstrup kh. Lancet. 2025 Oct 17:S0140-6736(25)01742-8. doi: 10.1016/S0140-6736(25)01742-8. Online ahead of print. Lancet. 2025. PMID: 41115437
Relative vaccine effectiveness of high-dose vs. standard-dose influenza vaccine against clinical outcomes according to history of atrial fibrillation: a pre-specified analysis of the DANFLU-1 randomized trial.
Espersen C, Johansen ND, Modin D, Janstrup KH, Loiacono MM, Harris RC, Biering-Sørensen T. Espersen C, et al. Among authors: janstrup kh. Eur Heart J Open. 2025 Aug 21;5(5):oeaf102. doi: 10.1093/ehjopen/oeaf102. eCollection 2025 Sep. Eur Heart J Open. 2025. PMID: 40927272 Free PMC article.
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
Johansen ND, Modin D, Loiacono MM, Harris RC, Dufournet M, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Bartholdy KV, Bernholm KF, Borchsenius JIH, Davidovski FS, Davodian LW, Dons M, Duus LS, Espersen C, Fussing FH, Jensen AMR, Landler NE, Langhoff ACF, Lassen MCH, Nielsen AB, Ottosen CI, Sengeløv M, Skaarup KG, Solomon SD, Landray MJ, Gislason GH, Køber L, Ralfkiaer L, Nealon J, Sivapalan P, Martel CJ, Jensen JUS, Biering-Sørensen T. Johansen ND, et al. Among authors: janstrup kh. N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509907. Online ahead of print. N Engl J Med. 2025. PMID: 40888720
Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine: A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial.
Pareek M, Johansen ND, Modin D, Loiacono MM, Harris RC, Dufournet M, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Bartholdy KV, Bernholm KF, Borchsenius JIH, Davidovski FS, Davodian LW, Dons M, Duus LS, Espersen C, Fussing FH, Jensen AMR, Landler NE, Langhoff ACF, Lassen MCH, Nielsen AB, Ottosen CI, Sengeløv M, Skaarup KG, Solomon SD, Landray MJ, Gislason GH, Køber L, Sivapalan P, Martel CJ, Jensen JUS, Biering-Sørensen T. Pareek M, et al. Among authors: janstrup kh. JAMA Netw Open. 2025 Aug 1;8(8):e2536889. doi: 10.1001/jamanetworkopen.2025.36889. JAMA Netw Open. 2025. PMID: 40884443 Free PMC article.
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Johansen ND, Modin D, Loiacono MM, Harris RC, Dufournet M, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Bartholdy KV, Bernholm KF, Borchsenius JIH, Davidovski FS, Davodian LW, Dons M, Duus LS, Espersen C, Fussing FH, Jensen AMR, Landler NE, Langhoff ACF, Lassen MCH, Nielsen AB, Ottosen CI, Sengeløv M, Skaarup KG, Pareek M, Solomon SD, Landray MJ, Gislason GH, Køber L, Sivapalan P, Martel CJ, Jensen JUS, Biering-Sørensen T. Johansen ND, et al. Among authors: janstrup kh. JAMA Cardiol. 2025 Aug 30:e253460. doi: 10.1001/jamacardio.2025.3460. Online ahead of print. JAMA Cardiol. 2025. PMID: 40884442 Free PMC article.
High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial.
Pareek M, Johansen ND, Modin D, Loiacono MM, Harris RC, Dufournet M, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Bartholdy KV, Bernholm KF, Borchsenius JIH, Davidovski FS, Davodian LW, Dons M, Duus LS, Espersen C, Fussing FH, Jensen AMR, Landler NE, Langhoff ACF, Lassen MCH, Nielsen AB, Ottosen CI, Sengeløv M, Skaarup KG, Solomon SD, Landray MJ, Gislason GH, Køber L, Sivapalan P, Martel CJ, Jensen JUS, Biering-Sørensen T. Pareek M, et al. Among authors: janstrup kh. Eur Heart J. 2025 Nov 3;46(41):4282-4290. doi: 10.1093/eurheartj/ehaf678. Eur Heart J. 2025. PMID: 40884413 Free PMC article. Clinical Trial.
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trial.
Espersen C, Johansen ND, Modin D, Janstrup KH, Nealon J, Samson S, Loiacono MM, Harris RC, Andrew MK, Larsen CS, Jensen AMR, Landler NE, Claggett BL, Solomon SD, Landray MJ, Gislason GH, Køber L, Jensen JUS, Sivapalan P, Biering-Sørensen T. Espersen C, et al. Among authors: janstrup kh. J Infect Dis. 2025 Aug 13:jiaf420. doi: 10.1093/infdis/jiaf420. Online ahead of print. J Infect Dis. 2025. PMID: 40796377
28 results